BD (Becton, Dickinson and Company) has launched HemoSphere Alta, its most advanced hemodynamic monitoring platform to date.
The system is equipped with predictive algorithms and artificial intelligence and designed to alert clinicians about possible blood pressure instabilities before they become dangerous.
BD Launches Smart Monitor for Safer Patient Care
This launch marks the first major product debut from BD’s Advanced Patient Monitoring division since its recent acquisition.
More than just a monitor, HemoSphere Alta blends AI with real-time clinical data to support fast, informed decisions in critical moments, especially during surgery or intensive care procedures.
One of the most groundbreaking features is the Cerebral Autoregulation Index (CAI), a first-of-its-kind tool that gives doctors insights into how well a patient’s brain can maintain stable blood flow even when blood pressure fluctuates.
This is made possible by combining data from sensors placed on the forehead and an arterial line. It gives clinicians a clearer picture of a patient’s unique blood pressure needs.
The platform also includes the Acumen Hypotension Prediction Index (HPI), software that predicts low blood pressure episodes. Studies show that this predictive alert system can reduce the depth and duration of such episodes, which helps to lower the risks of complications during care.
“Research over the past two decades has demonstrated the wide variability of the lower limit of cerebral blood flow autoregulation between individuals, as well as the risk for patient morbidity and mortality when blood pressure is maintained below this threshold,” Dr. Charles Hogue stated, chairman of the Department of Anesthesiology at Northwestern University Feinberg School of Medicine in Chicago.
“The availability of the novel Cerebral Autoregulation Index provides clinicians with a tool to detect conditions of impaired autoregulation and can help identify a patient’s lower limit of autoregulation,” he said.
Also Read: Huawei Set to Begin Mass Shipment of AI Chip Amid Challenges
